Trials / Unknown
UnknownNCT05305183
A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis
A Randomized, Double-blinded, Active-controlled, Multicentered Phase III Trial to Assess the Efficacy and Safety of Minodronate Tablets in Postmenopausal Women With Osteoporosis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 330 (estimated)
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD · Industry
- Sex
- Female
- Age
- 46 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
In the randomized, active-controlled, double-blinded, multicenter study, the efficacy and safety of monthly oral minodronate were examined and compared to that of weekly oral alendronate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Minodronate Tablets and Alendronate Sodium Tablets-matching placebo;Alendronate Sodium Tablets and Minodronate Tablets -matching placebo | all subjects will receive Calcium Carbonate and Vitamin D3 Tablets as basic medication. |
Timeline
- Start date
- 2022-05-31
- Primary completion
- 2023-05-31
- Completion
- 2024-05-31
- First posted
- 2022-03-31
- Last updated
- 2022-03-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05305183. Inclusion in this directory is not an endorsement.